infi Revenue and Competitors
Estimated Revenue & Valuation
- infi's estimated annual revenue is currently $101.5k per year.
- infi received $16.0M in venture funding in October 2017.
- infi's estimated revenue per employee is $14,500
- infi's total funding is $538M.
Employee Data
- infi has 7 Employees.
- infi grew their employee count by -12% last year.
infi's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Architect | Reveal Email/Phone |
infi Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.3M | 458 | 5% | $127.5M | N/A |
#2 | $0.1M | 7 | 0% | $2.2M | N/A |
#3 | $0.5M | 7 | -12% | N/A | N/A |
#4 | $6.7M | 51 | 13% | N/A | N/A |
#5 | $64.1M | 348 | 20% | $147M | N/A |
#6 | $9.8M | 75 | -14% | N/A | N/A |
#7 | $0.1M | 7 | -12% | $538M | N/A |
#8 | $13.1M | 90 | -22% | $64.5M | N/A |
#9 | $0.1M | 7 | 0% | $13.3M | N/A |
#10 | $18M | 124 | 23% | N/A | N/A |
What Is infi?
infi is changing how millions of people around the world think, feel, decide and behave with its EmpathAI (Empathetic AI) platform. Using Deep Psychology to drive Deep Machine Learning and apply it to powerful predictive algorithms, EmpathAI offers unprecedented insights into each individuals unique traits, feelings and internal motivators. By replicating the thought processes of the human brain in the digital world, Infi knows what really matters, and what every individual really needs, in real-time. Welcome to the infi era
keywords:N/A
$538M
Total Funding
7
Number of Employees
$101.5k
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
infi News
Infinity Pharmaceuticals (NASDAQ:INFI Get Rating) will post its quarterly earnings results after the market closes on Tuesday, May 3rd.
Infinity Pharmaceuticals (NASDAQ:INFI Get Rating) will post its quarterly earnings results after the market closes on Tuesday, May 3rd.
Head to Head Review: AstraZeneca (NASDAQ:AZN) and Infinity Pharmaceuticals (NASDAQ:INFI). Posted by admin on Apr 22nd, 2022.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Receives Average Recommendation of Buy from Analysts. Posted by admin on Apr 19th, 2022.
Head to Head Review: AstraZeneca (NASDAQ:AZN) and Infinity Pharmaceuticals (NASDAQ:INFI). Posted by admin on Apr 22nd, 2022.
Other Companies in Tel Aviv
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | -12% | $45M |
#2 | $0.9M | 7 | -46% | N/A |
#3 | $0.5M | 7 | -12% | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.1M | 7 | 0% | $4.3M |
infi Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-10-31 | $16.0M | First | Article |